Aferrix

Diagnostic Tools for Iron Toxicity in Body Fluids

Health Tech & Life Sciences
Non Active, Jan 2023 ceased to operate
Mature Ashdod, Israel Founded 2002
LinkedIn
Last updated 2026-06-18
Total raised
Last:
Stage
Mature
Founded
2002
Headcount
1-10
HQ
Ashdod, Israel
Sector
Health Tech & Life Sciences

About

Aferrix develops tools for the early diagnosis and monitoring of serum iron toxicity. The companys solutions include methods that quantify different forms of toxic iron not detected by conventional tests. Aferrix offers iron testing services and kits for research and treatment centers specializing in iron overload diseases (e.g. thalassemia, hemochromatosis, and myelodysplastic syndrome) and for pharmaceutical companies that are developing iron chelators. All of the companys products are CE marked for IVD use.

Funding history · 1 round · — total

Date unknown

Q&A

What is Aferrix's primary business?
Aferrix develops diagnostic tools for the early diagnosis and monitoring of serum iron toxicity, offering solutions that quantify toxic iron forms not detected by conventional tests.
When was Aferrix founded?
Aferrix was founded in February 2002.
What is the current status of Aferrix?
Aferrix is currently inactive, having ceased operations in January 2023.
What types of customers does Aferrix target?
Aferrix targets customers in Healthcare & Life Sciences, including laboratories, providers, life sciences companies, pharmaceuticals, and biotechnology firms.
What is Aferrix's primary sector?
Aferrix's primary sector is Health Tech & Life Sciences.
What is the product stage of Aferrix's offerings?
Aferrix's products are released and are CE marked for IVD use.
Has Aferrix received any funding?
Yes, Aferrix received funding from Gefen Biomed Investments.

Team · 1

Founder · Founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProvidersLife SciencesPharmaceuticalsBiotechnology
Business model
B2B

Highlights

1 Patents

Tags

diagnosticspharma-companiesblood-testmeasurementsmedical-technologieslaboratoriesmonitoringdetection
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)